GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

Wellness influencer Torey Casey, known as @certifiedhealthnut, advocates for urine therapy, claiming it provides health ...

The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery patients.

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, ...

Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many people mistakenly dismiss.

Researchers from Cambridge University have developed a first-of-its-kind test that can pick up “zombie cells”, linked to the early stages of lung cancer. By detecting these aging (senescent) cells in ...

(HealthDay News) — Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma ... show whether the cancer has actually returned then ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...